N/A
N=450
Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)
Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03694171 ↗Enrolled (actual)
450
Serious AEs
—
Results posted
Sep 2025
Primary outcome: Primary: Proportion of Patients Being Receiving Treatment Administration After Diagnosis — 372 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Any cancer treatment (Other)
- Age
- Older Adult · 65+ yrs
- Sex
- All
- Sponsor
- Institut Bergonié
- Primary completion
- Nov 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Proportion of Patients Being Receiving Treatment Administration After Diagnosis |
372 | — |
| PRIMARY The Probability of Being Dead at One Year |
35.5 | — |
Summary
The growing incidence of cancer associated to an aging population represents an epidemiologic reality that requires questioning access to care and prognosis in elderly with cancer, for which disparities have been highlighted. However, generally speaking, studies are limited in that they overlook geriatric-specific factors. The aim of this work was to study sociodemographic, socioeconomic and clinical determinants of access to care (cancer stage, cancer treatment) and prognosis (functional decline, survival) in elderly cancer patients.
Eligibility Criteria
- Age ≥ 65 years
- Alive on January 1st 2005 ( PAQUID or 3-City cohorts) or included in the AMI cohort study
- Cancer diagnosis recorded in one of the cancer registries in Gironde, French department
Data sourced from ClinicalTrials.gov (NCT03694171). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.